FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2098496680> ?p ?o ?g. }

• W2098496680 endingPage "S57" @default.
• W2098496680 startingPage "S43" @default.
• W2098496680 abstract "A comprehensive literature study was conducted to evaluate the levels of evidence (LEs) in publications on the diagnosis and staging of penile cancer. Recommendations from the available evidence were formulated and discussed by the full panel of the International Consultation on Penile Cancer in November 2008. The final grades of recommendation (GRs) were assigned according to the LE of the relevant publications. The following consensus recommendations were accepted. Fine needle aspiration cytology should be performed in all patients (with ultrasound guidance in those with nonpalpable nodes). If the findings are positive, therapeutic, rather than diagnostic, inguinal lymph node dissection (ILND) can be performed (GR B). Antibiotic treatment for 3-6 weeks before ILND in patients with palpable inguinal nodes is not recommended (GR B). Abdominopelvic computed tomography (CT) and magnetic resonance imaging (MRI) are not useful in patients with nonpalpable nodes. However, they can be used in those with large, palpable inguinal nodes (GR B). The statistical probability of inguinal micrometastases can be estimated using risk group stratification or a risk calculation nomogram (GR B). Surveillance is recommended if the nomogram probability of positive nodes is <0.1 (10%). Surveillance is also recommended if the primary lesion is grade 1, pTis, pTa (verrucous carcinoma), or pT1, with no lymphovascular invasion, and clinically nonpalpable inguinal nodes, but only provided the patient is willing to comply with regular follow-up (GR B). In the presence of factors that impede reliable surveillance (obesity, previous inguinal surgery, or radiotherapy) prophylactic ILND might be a preferable option (GR C). In the intermediate-risk group (nomogram probability .1-.5 [10%-50%] or primary tumor grade 1-2, T1-T2, cN0, no lymphovascular invasion), surveillance is acceptable, provided the patient is informed of the risks and is willing and able to comply. If not, sentinel node biopsy (SNB) or limited (modified) ILND should be performed (GR B). In the high-risk group (nomogram probability >.5 [50%] or primary tumor grade 2-3 or T2-T4 or cN1-N2, or with lymphovascular invasion), bilateral ILND should be performed (GR B). ILND can be performed at the same time as penectomy, instead of 2-6 weeks later (GR C). SNB based on the anatomic position can be performed, provided the patient is willing to accept the potential false-negative rate of </=25% (GR C). Dynamic SNB with lymphoscintigraphic and blue dye localization can be performed if the technology and expertise are available (GR C). Limited ILND can be performed instead of complete ILND to reduce the complication rate, although the false-negative rate might be similar to that of anatomic SNB (GR C). Frozen section histologic examination can be used during SNB or limited ILND. If the results are positive, complete ILND can be performed immediately (GR C). In patients with cytologically or histologically proven inguinal metastases, complete ILND should be performed ipsilaterally (GR B). In patients with histologically confirmed inguinal metastases involving >/=2 nodes on one side, contralateral limited ILND with frozen section analysis can be performed, with complete ILND if the frozen section analysis findings are positive (GR B). If clinically suspicious inguinal metastases develop during surveillance, complete ILND should be performed on that side only (GR B), and SNB or limited ILND with frozen section analysis on the contralateral side can be considered (GR C). Endoscopic ILND requires additional study to determine the complication and long-term survival rates (GR C). Pelvic lymph node dissection is recommended if >/=2 proven inguinal metastases, grade 3 tumor in the lymph nodes, extranodal extension (ENE), or large (2-4 cm) inguinal nodes are present, or if the femoral (Cloquet's) node is involved (GR C). Performing ILND before pelvic lymph node dissection is preferable, because pelvic lymph node dissection can be avoided in patients with minimal inguinal metastases, thus avoiding the greater risk of chronic lymphedema (GR B). In patients with numerous or large inguinal metastases, CT or MRI should be performed. If grossly enlarged iliac nodes are present, neoadjuvant chemotherapy should be given and the response assessed before proceeding with pelvic lymph node dissection (GR C). Antibiotic treatment should be started before surgery to minimize the risk of wound infection (GR C). Perioperative low-dose heparin to prevent thromboembolic complications can be used, although it might increase lymph leakage (GR C). The skin incision for ILND should be parallel to the inguinal ligament, and sufficient subcutaneous tissue should be preserved to minimize the risk of skin flap necrosis (GR B). Sartorius muscle transposition to cover the femoral vessels can be used in radical ILND (GR C). Closed suction drainage can be used after ILND to prevent fluid accumulation and wound breakdown (GR B). Early mobilization after ILND is recommended, unless a myocutaneous flap has been used (GR B). Elastic stockings or sequential compression devices are advisable to minimize the risk of lymphedema and thromboembolism (GR C). Radiotherapy to the inguinal areas is not recommended in patients without cytologically or histologically proven metastases nor in those with micrometastases, but it can be considered for bulky metastases as neoadjuvant therapy to surgery (GR B). Adjuvant radiotherapy after complete ILND can be considered in patients with multiple or large inguinal metastases or ENE (GR C). Adjuvant chemotherapy after complete ILND can be used instead of radiotherapy in patients with >/=2 inguinal metastases, large nodes, ENE, or pelvic metastases (GR C). Follow-up should be individualized according to the histopathologic features and the management chosen for the primary tumor and inguinal nodes (GR B)." @default.
• W2098496680 created "2016-06-24" @default.
• W2098496680 creator A5007710281 @default.
• W2098496680 creator A5007886217 @default.
• W2098496680 creator A5010712368 @default.
• W2098496680 creator A5048135266 @default.
• W2098496680 creator A5051291045 @default.
• W2098496680 creator A5060616205 @default.
• W2098496680 date "2010-08-01" @default.
• W2098496680 modified "2023-10-17" @default.
• W2098496680 title "Management of the Lymph Nodes in Penile Cancer" @default.
• W2098496680 cites W111023852 @default.
• W2098496680 cites W114996810 @default.
• W2098496680 cites W11671095 @default.
• W2098496680 cites W117035252 @default.
• W2098496680 cites W12080193 @default.
• W2098496680 cites W121127050 @default.
• W2098496680 cites W1568892371 @default.
• W2098496680 cites W1604879837 @default.
• W2098496680 cites W180187181 @default.
• W2098496680 cites W1825332025 @default.
• W2098496680 cites W18270963 @default.
• W2098496680 cites W1965982732 @default.
• W2098496680 cites W1967187146 @default.
• W2098496680 cites W1969367663 @default.
• W2098496680 cites W1972457727 @default.
• W2098496680 cites W1981484813 @default.
• W2098496680 cites W1982211550 @default.
• W2098496680 cites W1985398930 @default.
• W2098496680 cites W1986421141 @default.
• W2098496680 cites W1988046290 @default.
• W2098496680 cites W1988066843 @default.
• W2098496680 cites W1989629147 @default.
• W2098496680 cites W1992600408 @default.
• W2098496680 cites W1993098711 @default.
• W2098496680 cites W1996493747 @default.
• W2098496680 cites W1996706019 @default.
• W2098496680 cites W1999693638 @default.
• W2098496680 cites W2001159290 @default.
• W2098496680 cites W2002557319 @default.
• W2098496680 cites W2003299254 @default.
• W2098496680 cites W2004527412 @default.
• W2098496680 cites W2005195199 @default.
• W2098496680 cites W2008649250 @default.
• W2098496680 cites W2009645173 @default.
• W2098496680 cites W2010239390 @default.
• W2098496680 cites W2011620608 @default.
• W2098496680 cites W2011675977 @default.
• W2098496680 cites W2011711666 @default.
• W2098496680 cites W2013672807 @default.
• W2098496680 cites W2015332537 @default.
• W2098496680 cites W2018687779 @default.
• W2098496680 cites W2021166326 @default.
• W2098496680 cites W2021358748 @default.
• W2098496680 cites W2022345748 @default.
• W2098496680 cites W2025013586 @default.
• W2098496680 cites W2028717353 @default.
• W2098496680 cites W2032535174 @default.
• W2098496680 cites W2033034792 @default.
• W2098496680 cites W2033985812 @default.
• W2098496680 cites W2034457828 @default.
• W2098496680 cites W2034498859 @default.
• W2098496680 cites W2034540002 @default.
• W2098496680 cites W2034888707 @default.
• W2098496680 cites W2038217098 @default.
• W2098496680 cites W2038713356 @default.
• W2098496680 cites W2041045315 @default.
• W2098496680 cites W2041599986 @default.
• W2098496680 cites W2042472674 @default.
• W2098496680 cites W2049130473 @default.
• W2098496680 cites W2052030445 @default.
• W2098496680 cites W2053073359 @default.
• W2098496680 cites W2054729220 @default.
• W2098496680 cites W2056718049 @default.
• W2098496680 cites W2064069679 @default.
• W2098496680 cites W2064100769 @default.
• W2098496680 cites W2065977839 @default.
• W2098496680 cites W2068822883 @default.
• W2098496680 cites W2069637466 @default.
• W2098496680 cites W2070152459 @default.
• W2098496680 cites W2074804647 @default.
• W2098496680 cites W2075005443 @default.
• W2098496680 cites W2075415215 @default.
• W2098496680 cites W2077466239 @default.
• W2098496680 cites W2077484515 @default.
• W2098496680 cites W2078049525 @default.
• W2098496680 cites W2080637120 @default.
• W2098496680 cites W2082706327 @default.
• W2098496680 cites W2085380111 @default.
• W2098496680 cites W2085559723 @default.
• W2098496680 cites W2086448714 @default.
• W2098496680 cites W2086544691 @default.
• W2098496680 cites W2089118858 @default.
• W2098496680 cites W2091725395 @default.
• W2098496680 cites W2093639450 @default.
• W2098496680 cites W2093983164 @default.
• W2098496680 cites W2094014005 @default.
• W2098496680 cites W2100600610 @default.

• next